chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in left arm started shortly after vaccine, felt like typical post vaccination soreness. Progressed the next morning to pain all down my left arm and across my upper back. I also was fatigued and and generally felt bad. The next morning my left arm distal to the vaccination sites was red, swollen, and warm. The pain/fatigue got better but the inflammation continues still.
The patient was asked to wait 30 minutes after receiving post-exposure rabies treatment on 3/1/05.  15 minutes after receiving 10 mL of HRIG (Human Rabies Immune Globulin) and 1 mL of Rab-Avert Rabies vaccine, she c/o itching on her right index finger.  The HRIG was administered to the right index finger and face where the bites were located and the rest was administered in the right and left buttock.  I observed a rash starting on both arms and spreading upward.  She was taken back into the exam room and administered 50 mg of Benadryl po.  The doctor evaluated her and then ordered .5 mL of epinephrine SQ.  Her vital signs were evaluated every 10-15 minutes; no further s/s of distress occurred.  The doctor gave intructions to the grandmother on what to do if she experienced any further s/s of an allergic reaction and was sent home after her vital signs continued to be within the normal range.  A follow up phone call to the grandmother was made on Wed., March 2nd and she reported that the child was fine, somewhat sore from the injections.
This spontaneous report was received from a Registered Nurse (R.N.) referring to an identified patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unspecified date, the patient was vaccinated with an improperly stored dose of PROQUAD lot # N025929 expiring on 18-MAR-2019, for prophylaxis (dosage schedule and route of administration were not reported). Concomitant therapies included sterile diluent (MERCK STERILE DILUENT) properly stored. The administered dose of the vaccine experienced a temperature excursion of 6°F to 14°F for 3 hours and of 15°F to 46°F (21°F) for another 2 hours , as recorded by a data logger. The vaccine had not had any previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved. This is one of several reports from the same source.; Sender's Comments: US-009507513-1805USA015000:Original Case : 1805USA015000.
COVID-19; greater than 35 days between Covid 19 first and second vaccination; sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), PRODUCT DOSE OMISSION ISSUE (greater than 35 days between Covid 19 first and second vaccination) and VACCINATION SITE PAIN (sore right injection site arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 03-May-2021.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (greater than 35 days between Covid 19 first and second vaccination) and VACCINATION SITE PAIN (sore right injection site arm). On 03-May-2021, the patient experienced COVID-19 (COVID-19). On 03-Jun-2021, PRODUCT DOSE OMISSION ISSUE (greater than 35 days between Covid 19 first and second vaccination) had resolved. At the time of the report, COVID-19 (COVID-19) and VACCINATION SITE PAIN (sore right injection site arm) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-May-2021, SARS-CoV-2 test: unknown (Positive) COVID-19 Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information were given by the reporter.
I HAVE BEEN HEARING COWARDICE VOICES THREATENING MY LIFE, TELLING ME TO GO AWAY AND I AM DEAD. ALL IN ORDER. AS YOU ARE AWARE, I WILL NEVER GIVE-IN FOR THIS COWARDICE ACTS, I AM NOT WELCOME IN YOU MIST AND LEAVE ME ALONE. LEAVE MY FAMILY ALONE, YOU ALL KNOW WHAT IS HAPPENING.
She started feeling lightheaded and dizzy, we were at the doctor's office already for a visit. They did bloodwork at that time; it did come back showing that she was anemic. She was prescribed liquid iron that we are giving her and tracking for six weeks, since she has absorption issues. If her body has not absorbed the iron as needed we will go forward with the transfusion.
Head pain on the left side of head; This is a spontaneous case from, initially received from a pharmacist on 30-Oct-2018, concerning a 62-year-old, adult female patient.  The patient did not have any medical history. The patient did not receive any concomitant medications.  On 26-Oct-2018, the patient was administered Afluria Quadrivalent (influenza vaccine, dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 03244611A and expiry date: 30-Jun-2019) for active immunization against influenza.   On an unspecified date in Oct-2018, after the vaccination, the patient experienced head pain on the left side of her head which was reported on 29-Oct-2018. It was reported that, the patient was not hospitalized.  As of 30-Oct-2018, the patient had not yet recovered from the event.  The reporter assessed the case as non-serious.   Significant case amendment (30-Oct-2018): The patient's initials was changed in patient tab. No changes were made in narrative.  Non-significant case amendment (30-Oct-2018): The statement "A 62-year-old, female patient experienced head pain on the left side of her head, unspecified date in Oct-2018 after administration of Afluria Quadrivalent" was changed to "A 62-year-old, female patient experienced head pain on the left side of her head, within a week after administration of Afluria Quadrivalent" in the case comment. No changes were made in the narrative.  Non-significant follow up received on 28-Jan-2019: An attempt was made to contact the reporter but was unsuccessful. The case was considered as lost to follow up. Med info number (SEQ19-07634) was added in the additional information tab. No changes were made in the narrative.; Reporter's Comments: A 62-year-old, female patient experienced head pain on the left side of her head, within a week after administration of Afluria Quadrivalent. The company assessed the causality of the event as related to the suspect vaccine due to the plausible temporal relationship between the event and suspect vaccine.
After receiving his covid shot and then waiting for his family member to get his covid shot, the patient was asked to sit outside and wait for 20 minutes to monitor for any reactions to the vaccine. 5 to 10 minutes after leaving the immunization room, patient fainted in the front of the pharmacy. His family member laid him down and 911 was called. He regained consciousness and was answering questions. He remained laying down until the ambulance came to escort him to a hospital.
TIRED, SORE, PAIN, MUSCLE TWITCHING IN LIPS, FOREARM, RT SIDE OF BODY, EYES. FROM FACE TO CALF. NO HANDS OR FEET AFFECTED.
A report has been received from a Health Professional concerning a 7 year old, female subject, who had been receiving nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on an unknown date. It was reported, they gave expired FLUMIST QUADRIVALENT to the patient (Preferred Term: Expired drug administered) which started on 15-Jan-2014.The outcome of the event of gave expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
face was flushed after the first dose and was red for most of the day; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (Daughter).  A female patient of unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, after the vaccination, the patient face was flushed after the first dose and was red for most of the day. The outcome of the event was unknown.  No follow-up attempts possible. No further information expected.  Follow-up (PRD/SRD (11May2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
I did not have an adverse reaction to the vaccine.  I tested positive for COVID-19 via home test on 07/28/2022. We had traveled out-of-state for a family gathering and got sick from that trip. I wasn't running a temperature but I just didn't feel good. I contacted my doctor and was prescribed Paxlovid.  My symptoms was not bad so I'm not sure that it really helped me.
17 year old received Moderna vaccine when it is only authorized for 18 year olds and older.
itching/itching more severely so my entire body almost has a rash; I have got a rash/itching more severely so my entire body almost has a rash/body rash; I thought it was a dry skin/My legs specially are itching and dry; This is a spontaneous report received from a non-contactable reporter(s) (Nurse). The reporter is the patient.  An 86-year-old female patient (unknown if pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "I had Covid", start date: Jul2021 (unspecified if ongoing), notes: I had Covid '21Jul' after I cleared the infection and recovered. The patient took concomitant medications. The following information was reported: PRURITUS (non-serious), outcome "unknown", described as "itching/itching more severely so my entire body almost has a rash"; RASH (non-serious), outcome "unknown", described as "I have got a rash/itching more severely so my entire body almost has a rash/body rash"; DRY SKIN (non-serious), outcome "unknown", described as "I thought it was a dry skin/My legs specially are itching and dry". Therapeutic measures were taken as a result of pruritus, rash, dry skin.  Additional information: The patient had been on blood thinner (unspecified) for weeks. Ever since patient got the vaccine, after having disease, she had Covid in Jul2021, after it cleared the infection and recovered. The patient got her first Pfizer vaccine and started itching. The patient couldn't figure it out, thought it was dry skin also got a rash. She had itching more severely so her entire body almost had a rash. Her legs specially are itching and dry. She realized that she was a dried-up old lady. She had been using Cortisol as treatment. She just wanted to report the itching and the body rash. She read literature and found information about blood thinner. She mentioned that she had not taken Benadryl as she doesn't want to get sleepy (no further information).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201188266 same product, patient, different AEs, different dose;
his arm is extremely sore at the site of the injection; He is also running a fever (100F); This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (his arm is extremely sore at the site of the injection) and PYREXIA (He is also running a fever (100F)) in an 89-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Nov-2023, the patient received dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On 01-Nov-2023, the patient experienced VACCINATION SITE PAIN (his arm is extremely sore at the site of the injection) and PYREXIA (He is also running a fever (100F)). At the time of the report, VACCINATION SITE PAIN (his arm is extremely sore at the site of the injection) and PYREXIA (He is also running a fever (100F)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Nov-2023, Body temperature: 100 F.         No concomitant medication was reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-046502 (Patient Link).
wife had pfizer vaccine/ she became sick with covid 2 weeks ago; wife had pfizer vaccine/ she became sick with covid 2 weeks ago; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "wife had pfizer vaccine/ she became sick with covid 2 weeks ago". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Covid, notes: She became sick with covid 2 weeks ago.  Clinical information: Friends of reporter, wife had Pfizer vaccine and her husband Moderna. She became sick with covid 2 weeks ago.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events drug ineffective and covid-19 and BNT162B2.
ACHY JOINTS; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On MAR-2021, the subject experienced achy joints. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of achy joints was not reported. This report was non-serious.
Child felt dizzy, nauseated, then had syncopal episode immediately after vaccination administration.  There was less than 30 seconds of some generalized tremors and cyanosis of the lips.  The patient awoke spontaneously and felt tired, dizzy, and complained of headache.  She drank Pedialyte and ate some cookies in the office and after a period of rest (about 45 minutes) she left the office on foot with her mother.
pt recv vax & go so sick had to see MD; pt was in bed seriously ill w/fever for an entire wk; pt remained fatigued; pt noticed had major blood vessels breaking in face; also joint pain & fatigue & visual problems; also pain
Shortly after receiving the vaccine, I developed a mild tightness in my throat that progressed mildly until I took Dayquil.
After about 25 minutes,  had numbness in my tongue and a strong metallic taste; After about 25 minutes, had numbness in my tongue and a strong metallic taste; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Jun2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known allergies to medications, food, or other products. The patient did not have any past drug history. The patient received unspecified medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jun2021 at 11:30, about 25 minutes after vaccination, the patient experienced numbness in his tongue and a strong metallic taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events numbness in tongue and a strong metallic taste was resolved on 05Jun2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Paxlovid indication=Treatment of COVID-19; Paxlovid indication=Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Nurse) from product quality group. The reporter is the patient.  A 77-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Feb2021 at 12:30 as dose 1, single (Lot number: EN5318), in right arm, on 24Feb2021 at 03:00 as dose 2, single (Lot number: El9269), in right arm, on 29Sep2021 at 12:00 as dose 3 (booster), single (Lot number: PC3183), in right arm and on 01Apr2022 at 12:00 as dose 4 (booster), single (Lot number: Fj4991) at the age of 77 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "HTN" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "anxiety" (unspecified if ongoing). Patient had no known allergies. Concomitant medication(s) included: SYNTHROID, start date: 01Jan2002; SERTRALINE, also reported as other medication in 2weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Paxlovid indication=Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19 included Anti-viral Paxlovid started on 21Apr2022 and stopped on 25Apr2022. Reported as, On 28Apr2022 at 10:00, 3 to 4 days after 5th day of Paxlovid, achy and not feeling well, fatigue, next day awoke with sore throat and laryngitis, on following days heavy URI, the feelings of bronchitis with harsh non productive cough, no fever, tired and weak. S/S mild with starting Paxlovid on day 2 of onset of symptoms. Patient was not recovered from symptoms and no treatment received for symptoms.; Sender's Comments: Based on the information provide and plausible temporal association, the causality between BNT162B2 and events cannot be completely excluded.
extreme tiredness, extreme irritability complete body ache-from head to toe;soreness in area of inj starting 1/2hr p/each 3inj lasting 2-3 days w/sx the worst the first 12hr p/vax;
About 4 hours shots were given grandmother noted that patient had left sided facial swelling that had resolved by morning when the patient woke up.
fever of 100; covid; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on unknown date).   On 2nd August 2020, the patient received the 2nd dose of Shingrix. In August 2020, less than a week after receiving Shingrix, the patient experienced fever and coronavirus infection. On an unknown date, the outcome of the fever and coronavirus infection were unknown.   It was unknown if the reporter considered the fever and coronavirus infection to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient received 2nd dose of vaccine and had fever of 100 degree F. The patient was concerned whether it was due to shingle shot or covid. The event coronavirus infection was capture conservatively since no follow up was possible for the case.
6 days after injection, injection site is itchy, hard, and slightly swollen. It was fine until today.
Welt 4x3.5 2/15/17 pt waited for 15 mins no reaction. VIS given, Pt came in on 2/17/17 for PPD test reading and informed nurse of welt that had formed in right thigh where KINRIX Vaccine was given. Welt size 4x3.5.
Erythema multiforme x 3 days; no tx x/DPH for itching;
Patient developed unilateral facial numbness 2 days after the vaccine. The numbness subsided and was replaced with pain. No weakness or drooping. No eye involvement. Patient's pain was located on the right side of the jaw below the eye. Patient was treated with prednisone on the same schedule of dosage as used for Bell's Palsy. Patient saw immediate improvement from the prednisone and is no longer having the pain. She never developed any other complications.
Tested positive for Covid on May 17. 2022.  symptoms started on May 15.  Fever 103+  Aches Chills Diarrea
Pt given Hep A #1, about 1 hour after had DTaP #4. 30 sec loss of consciousness. Unclear if pt had breath hold spell versus seizure.
From initial information received on 11/5/04 from a physician regarding an adverse event, it was reported that a 54 year old female patient received a FLUZONE vaccination, lot U1478AA, administered in the right deltoid on 10/21/04. The route of administration was not reported. Approximately ten to fourteen days post vaccination (onset date reported as 10/31/04), the patient developed symptoms of diffuse myalgia of the neck and shoulders, which gradually progressed downward to the legs and feet. The patient was seen by a physician, who was to investigate for possible polymyositis. The patient's past medical history includes asthma. She also had an unspecified viral illness on 9/22/04. At the time of this report, the patient had not recovered from these events. From additional information received on 12/1/04 from the reporting physician, it was reported as of 11/23/04 the patient was improving but is still myalgic. Follow up information received on 7/20/05. Based upon additional medical information, this case is being upgraded to serious. It was reported that the patient still has bilateral lower extremity claudication symptoms of undetermined etiology. The events have been persistent since November 2004 and the patient has been seen by a neurologist. An EMG and non-invasive studies were negative. An MRI of the brain was completed on 2/7/05 and was negative. The results of an MRI of the spine are pending. The patient's past medical history is significant for mild spondylosis, which was diagnosed in October 1998. At the time of this report, the patient has not recovered from the events. (OMIC)
7/12/2021: Patient tested positive for COVID on 7/7/21 and was admitted on 7/12/21 by the transplant team after being hypoxic requiring additional oxygenation. diagnosed with widespread bilateral airspace disease typical for COVID-19 pneumonia.  completed remdesivir regimen on 7/16. receiving Baricitinib.  7.26.21: patient is still admitted as of the date of this report submission.
06/18/2022  I woke up with a cough, it felt like when I have had bronchitis. I had a fever that got up to 101. I tested positive for COVID with a home test. I took Mucinex and Advil or Tylenol. My doctor did not want me to take Tylenol or Advil because of my liver, so I stopped taking both.  The fever lasted for 2 days. I had an occasional cough that persisted, some congestion and was very tired.  I feel 100% again now.